CompuGroup Medical SE, DE0005437305

CompuGroup Medical SE, DE0005437305

09.11.2017 - 08:25:03

CompuGroup Medical SE - Third Quarter Results 2017

 

CompuGroup Medical SE - Third Quarter Results 2017 Koblenz, November 9, 2017 - Today, CompuGroup Medical SE (CGM) presented the financial report for the third quarter of 2017. The company plays a leading role in the development of global e-health solutions and enjoys market leadership in Germany as well as in other key European countries. CGM achieved revenue of EUR 138 million compared to EUR 136 million in the same period last year. The operating profit (EBITDA) reached EUR 28 million, same as in the third quarter 2016.

All business segments continue the trends from the beginning of the year in the third quarter with overall positive developments. For the first nine months of 2017 combined, revenue reached EUR 419 million, up from EUR 407 million last year. EBITDA reached EUR 92 million, up from EUR 89 million in the first three quarters of 2016.

In addition, CGM's ambulatory and dentist information systems as well as the hospital information system already received official approval for the productive operation within the Telematics Infrastructure (TI) in October. To be able to use the TI's advantages in due time, doctors, dentists, and psychotherapists need various TI components and services. The outcome of CGM's sales campaign was successful: In total, already 9,000 doctor and dental practices have ordered a TI connection package for an installation date in 2017.

Equally successful was the CGM CLINICAL deployment in the State Hospital of Feldkirch, Austria. This is the largest and most complex of the five hospitals in the roll out process for Vorarlberg's Hospital Betriebs GmbH (KHBG): It has more than 25 wards, 36,000 in-patient stays, 1,600 staff and about 600 nurses. The comprehensive HIS (Hospital Information System) implementation with KHBG represents the first time CGM has mapped essential core clinical processes using the CGM CLINICAL suite. With this go-live, CGM has now created the first truly large-scale and productive reference for the CGM CLINICAL hospital product and with a considerable proportion of this HIS solution now using new G3-based technology.

Frank Gotthardt, CEO and Chairman of the Board of CompuGroup Medical SE, stated: "We were able to provide a stable operating margin despite high ramp-up costs to prepare for the roll-out of the Telematics Infrastructure in Germany. Also, CGM has prepared an accelerated deployment process to install a substantial number of practices this year. The TI offers one of the most secure frame in healthcare systems worldwide. In this space, numerous and enormously important applications will be developed within the coming months and years - realizing the vast potential that lies within those products and solutions. As for the second point, the current success we are enjoying with KHBG in Austria is putting us in a strong starting position in terms of achieving an effective placement of CGM CLINICAL in our target markets."

CGM reaffirms the full year 2017 guidance presented in the 2016 Annual Report. Group revenue is expected to be in the range of EUR 600 million and EUR 630 million and operating profit (EBITDA) between EUR 138 million and EUR 150 million.

Conference Call for Journalists, Investors and Analysts: The management board of CompuGroup Medical SE will go through the results at a conference for analysts and investors today at 15:00 hours CET.

You can participate in this conference call by dialing one of the following phone numbers: +49 69 22 22 29 043 (Germany) +44 20 30 09 24 52 (UK) +1 85 54 02 77 66 (USA)Participant code: 66287042#

A presentation will be available for download on https://www.cgm.com/corp/ueber_uns_1/investor_relations/praesentationen/praesentationen.en.jsp prior to the conference call and can also be viewed live at:http://www.audio-webcast.com/cgi-bin/login.ssp?fn=verify_user&curPassword=compugroup1117

The financial report Q3 will be available for download on https://www.cgm.com/corp/ueber_uns_1/investor_relations/finanzberichte/zwischenberichte/zwischenbericht.en.jsp

CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of more than EUR 550 million, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of approximately 400,000 doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 20 countries and products in more than 46 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 4,300 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Editorial Staff Contact Information:

CompuGroup Medical SE Oliver Bruzek Chief Communication Officer T +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 E-Mail: press@cgm.com

09.11.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: CompuGroup Medical SE Maria Trost 21 56070 Koblenz

Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE0005437305 WKN: 543730 Indices: TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange   End of News DGAP News Service

627173  09.11.2017 

@ dgap.de

Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!